Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

BACKGROUND: Though the gut microbiome has been associated with efficacy of immunotherapy (ICI) in certain cancers, similar findings have not been identified for microbiomes from other body sites and their correlation to treatment response and immune related adverse events (irAEs) in lung cancer (LC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chau, Justin, Yadav, Meeta, Liu, Ben, Furqan, Muhammad, Dai, Qun, Shahi, Shailesh, Gupta, Arnav, Mercer, Keri Nace, Eastman, Evan, Hejleh, Taher Abu, Chan, Carlos, Weiner, George J., Cherwin, Catherine, Lee, Sonny T. M., Zhong, Cuncong, Mangalam, Ashutosh, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278634/
https://www.ncbi.nlm.nih.gov/pubmed/34256732
http://dx.doi.org/10.1186/s12885-021-08530-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278634/
https://www.ncbi.nlm.nih.gov/pubmed/34256732
http://dx.doi.org/10.1186/s12885-021-08530-z

Ejemplares similares